Development of Demodicosis after Omalizumab Injection
Ann Dermatol. 2023 May;35(Suppl 1):S182-S183. doi: 10.5021/ad.21.027.NO ABSTRACTPMID:37853907 | DOI:10.5021/ad.21.027 (Source: Annals of Dermatology)
Source: Annals of Dermatology - October 19, 2023 Category: Dermatology Authors: Sujin Park Yeongjoo Oh Howard Chu Chang Ook Park Source Type: research
Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality
Ann Dermatol. 2023 May;35(Suppl 1):S103-S106. doi: 10.5021/ad.21.177.ABSTRACTBullous pemphigoid (BP) is a chronic, autoimmune blistering disease that has concerning morbidity and mortality rates. Recently, several studies have focused on eosinophils due to their significant role in the pathogenesis of BP, considering that they are ubiquitous in the serum, tissue, and blister fluids of patients with BP. With this context, precision therapy that targets mediators of eosinophil activity could be a possible novel therapeutic strategy. Interleukin (IL)-5 is crucial for B-cell maturation, which consequently results in immunoglob...
Source: Annals of Dermatology - October 19, 2023 Category: Dermatology Authors: Hyeok-Jin Kwon Ki-Ho Kim Jung-Ho Yoon Source Type: research
Development of Demodicosis after Omalizumab Injection
Ann Dermatol. 2023 May;35(Suppl 1):S182-S183. doi: 10.5021/ad.21.027.NO ABSTRACTPMID:37853907 | DOI:10.5021/ad.21.027 (Source: Annals of Dermatology)
Source: Annals of Dermatology - October 19, 2023 Category: Dermatology Authors: Sujin Park Yeongjoo Oh Howard Chu Chang Ook Park Source Type: research
